C12N 2503/02
Drug screening
C12N2503/02 (Drug screening) appears on 637 US grants and 1,289 published applications in this corpus.
Search patents in C12N- Granted patents
- 637
- Published applications
- 1,289
- Assignees
- 708
- Inventors
- 2,784
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 5 | 0 |
| 1995 | 2 | 0 |
| 1996 | 6 | 0 |
| 1997 | 11 | 0 |
| 1998 | 10 | 0 |
| 1999 | 12 | 0 |
| 2000 | 12 | 0 |
| 2001 | 10 | 9 |
| 2002 | 18 | 56 |
| 2003 | 21 | 71 |
| 2004 | 13 | 52 |
| 2005 | 22 | 67 |
| 2006 | 23 | 39 |
| 2007 | 29 | 42 |
| 2008 | 20 | 40 |
| 2009 | 25 | 43 |
| 2010 | 24 | 41 |
| 2011 | 20 | 38 |
| 2012 | 28 | 34 |
| 2013 | 16 | 37 |
| 2014 | 18 | 32 |
| 2015 | 20 | 38 |
| 2016 | 28 | 44 |
| 2017 | 17 | 39 |
| 2018 | 22 | 45 |
| 2019 | 25 | 59 |
| 2020 | 24 | 67 |
| 2021 | 23 | 51 |
| 2022 | 19 | 64 |
| 2023 | 27 | 68 |
| 2024 | 20 | 80 |
| 2025 | 27 | 73 |
| 2026 | 32 | 60 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for inducing direct cross differentiation of somatic cell into motor neuron, and method for using same6 Oct 2026US 12,753,385 B2Unist (Ulsan National Institute of Science and Technology)
- Production method for stage 5 neurons6 Oct 2026US 12,753,386 B2Ricoh Company, Ltd.
- Liquid crystal scaffolds and use thereof for organoid, spheroid, and 3D cellaggregate manufacturing6 Oct 2026US 12,753,393 B2The Regents of the University of California
- Monoclonal antibody drug sensitivity in multiple myeloma patients6 Oct 2026US 12,754,180 B2The Regents of the University of Colorado, a body corporate
- Complex microfluidic models for ALS including NF biomarkers for ALS research and drug development29 Sep 2026US 12,748,102 B2Cedars-Sinai Medical Center
- Lymphoid tissues with switchable protein gradients8 Oct 2026US 2026/0308498 A1Georgia Tech Research Corporation
- Cancer models1 Oct 2026US 2026/0297534 A1Carcinotech Ltd
- Biomimetic 3d-printed hierarchical in vitro human synovium model for anti-arthritis drug evaluation24 Sep 2026US 2026/0286307 A1Center for Neuromusculoskeletal Restorative Medicine Limited
- Applications of hepatocyte co-culture system24 Sep 2026US 2026/0287577 A1LifeNet Health
- Directed differentiation protocols to derive bone fide spinal sensory interneurons17 Sep 2026US 2026/0275280 A1The Regents of the University of California
Most cited
By later US patents
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Pluripotential embryonic stem cells and methods of making same205US 5,453,357 AVanderbilt University · 1995
- Human CNS neural stem cells194US 5,968,829 ACytoTherapeutics, Inc. · 1999
- Neural transplantation using proliferated multipotent neural stem cells and their progeny176US 6,497,872 B1Neurospheres Holdings Ltd. · 2002